Physician
Nephrology
Dr. John R. Asplin, MD
|
|
Give Review
John Asplin is an expert in the field of Nephrology. He went to medical school at Emory University School of Medicine. Emory University School of Medicine has a rank of 23 in research and a 42 in primary care He has 1 awards "Fellow (ASNF)". John R. Asplin is also a published doctor. He has 81 paper published. The most recent paper is: Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
Publications
- Provider Variation in the Quality of Metabolic Stone Management.
- 1,25(OH)2D3-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
- The Interaction of thiol drugs and urine pH in the treatment of cystinuria.
- NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.
- Struvite urolithiasis and chronic urinary tract infection in a murine model of urinary diversion.
- Increased biological response to 1,25(OH)2D3 in genetic hypercalciuric stone-forming rats.
- Urine risk factors in children with calcium kidney stones and their siblings.
- Effect of diet orange soda on urinary lithogenicity.
- Variability in urinary oxalate measurements between six international laboratories.
- Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
- Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.
- Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.
- Medicine. Stopping the stones.
- The effect of restrictive bariatric surgery on urinary stone risk factors.
- Analysis of 24-hour urine parameters as it relates to age of onset of cystine stone formation.
- Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment.
- Thiosulfate reduces calcium phosphate nephrolithiasis.
- Prevalence of hyperoxaluria after bariatric surgery.
- Obesity and urolithiasis.
- Nephrolithiasis: introduction.
- Evaluation of the kidney stone patient.
- A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.
- Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
- Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.
- Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.
- Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
- Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
- Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.
- Hyperoxaluric calcium nephrolithiasis.
- Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
- Urinary stone risk factors in the siblings of patients with calcium renal stones.
- Reduced crystallization inhibition by urine from women with nephrolithiasis.
- A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis.
- Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
- The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease.
- Effects of Sex on Intra-Individual Variance in Urinary Solutes in Stone-Formers Collected from a Single Clinical Laboratory.
- A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic Acid load in non-stone formers and stone formers with hypercalciuria.
- Urine calcium excretion predicts bone loss in idiopathic hypercalciuria.
- Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
- Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.
- Medical reduction of stone risk in a network of treatment centers compared to a research clinic.
- Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization.
- The pathogenesis and treatment of kidney stones.
- Urinary cystine excretion and capacity in patients with cystinuria.
- Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
- Contribution of human uropontin to inhibition of calcium oxalate crystallization.
- Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
- Relationship between supersaturation and crystal inhibition in hypercalciuric rats.
- Evidence of calcium phosphate supersaturation in the loop of Henle.
- Uric acid stones.
- Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
- Patient adherence to long-term medical treatment of kidney stones.
- Proportional reduction of urine supersaturation during nephrolithiasis treatment.
- Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs.
- Differences in urine volume and supersaturation in 2 physician networks.
- Effect of grapefruit juice on urinary lithogenicity.
- Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.
- Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats.
- Clinical use of cystine supersaturation measurements.
- Does a high concentration of calcium in the urine cause an important renal concentrating defect in human subjects?
- Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
- Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria.
- Reduced crystallization inhibition by urine from men with nephrolithiasis.
- Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
- Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
- Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
- Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
- Responsiveness of hypercalciuria to thiazide in Dent's disease.
- Results of a prospective trial to compare normal urine supersaturation in children and adults.
- Chitosan does not reduce post-prandial urinary oxalate excretion.
- Supersaturation and stone composition in a network of dispersed treatment sites.
- Protein content of human apatite and brushite kidney stones: significant correlation with morphologic measures.
- Urinary metabolic evaluations in solitary and recurrent stone forming children.
- Effect of two sports drinks on urinary lithogenicity.
- Intestinal and renal effects of low-volume phosphate and sulfate cathartic solutions designed for cleansing the colon: pathophysiological studies in five normal subjects.
- The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass.
- Splenda® improves tolerance of oral potassium citrate supplementation for prevention of stone formation: results of a randomized double-blind trial.
- The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
- A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology.
- Urinary metabolic evaluations in normal and stone forming children.
Schools
Emory University School Of Medicine
University Cincinnati
University of Chicago
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Fellow (ASNF)
Education
-
University of Chicago -
University Hospital - University of Cincinnati College of Medicine -
Emory University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Patrick N. Cunningham, MD |
|
|
Dr. Stanley D. Crittenden, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eunice G. John, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Paparello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ana C. Ricardo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole S. Stankus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheldon Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Malathi Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonio M. Alvarado, MD |
|
Dr. Maria Sobrero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lillian C. Magana, MD |
|
|
Dr. Asa D. Koganti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shivani M. Shah, MD |
|
|
Dr. Kalyani Perumal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ignatius Tang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos A. Urdininea, MD |